0001209191-15-070584.txt : 20150914
0001209191-15-070584.hdr.sgml : 20150914
20150914182617
ACCESSION NUMBER: 0001209191-15-070584
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150910
FILED AS OF DATE: 20150914
DATE AS OF CHANGE: 20150914
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Arcadia Biosciences, Inc.
CENTRAL INDEX KEY: 0001469443
STANDARD INDUSTRIAL CLASSIFICATION: AGRICULTURE CHEMICALS [2870]
IRS NUMBER: 810571538
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 202 COUSTEAU PLACE
STREET 2: SUITE 200
CITY: DAVIS
STATE: X1
ZIP: 95618
BUSINESS PHONE: 602-429-0476
MAIL ADDRESS:
STREET 1: 4222 E. THOMAS RD
STREET 2: SUITE 245
CITY: PHOENIX
STATE: X1
ZIP: 85018
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Emlay Don
CENTRAL INDEX KEY: 0001640702
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37383
FILM NUMBER: 151106437
MAIL ADDRESS:
STREET 1: ARCADIA BIOSCIENCES, INC.
STREET 2: 202 COUSTEAU PLACE, SUITE 105
CITY: DAVIS
STATE: CA
ZIP: 95618
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-09-10
0
0001469443
Arcadia Biosciences, Inc.
RKDA
0001640702
Emlay Don
C/O ARCADIA BIOSCIENCES, INC.
202 COUSTEAU PLACE, SUITE 105
DAVIS
CA
95618
0
1
0
0
VP Regulatory and Compliance
Common Stock
2015-09-10
4
M
0
1588
0.44
A
12838
D
Common Stock
2015-09-10
4
S
0
548
5.2708
D
12290
D
Common Stock
2015-09-11
4
M
0
6397
0.44
A
18687
D
Common Stock
2015-09-11
4
S
0
2284
4.9181
D
16403
D
Common Stock
2015-09-14
4
M
0
2015
0.44
A
18418
D
Common Stock
2015-09-14
4
S
0
689
4.8061
D
17729
D
Employee Stock Option (right to buy)
0.44
2015-09-10
4
M
0
1588
0.00
D
2015-12-31
Common Stock
1588
8412
D
Employee Stock Option (right to buy)
0.44
2015-09-11
4
M
0
6397
0.00
D
2015-12-31
Common Stock
6397
2015
D
Employee Stock Option (right to buy)
0.44
2015-09-14
4
M
0
2015
0.00
D
2015-12-31
Common Stock
2015
0
D
The security transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Stock Trading Plan (the "Plan"), adopted by the Reporting Person effective June 12, 2015. Pursuant to the Plan and in compliance with the Issuer's IPO Lock-up Agreements with Credit Suisse Securities (USA) ("CSSU"), the Reporting Person paid the exercise price and CSSU sold shares only to satisfy the tax liability and costs. The balance of the shares will be held until the expiration of the IPO Lock-up Agreements.
This transaction was executed in multiple trades at prices ranging from $5.10 to $5.56. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $4.79 to $5.11. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $4.780 to $4.850. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The option is fully exercisable as of the date hereof.
Don Emlay, by Attorney in Fact, Wendy S. Neal
2015-09-14